Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
The latest announcement is out from DISA ( (SG:532) ).
DISA Limited’s subsidiary, Digital Life Line Pte. Ltd., has signed a licensing agreement with National University Hospital and National University of Singapore to commercialize MIDAS, a portable cataract diagnostic device. This initiative addresses the growing need for accessible cataract screening, facilitating early intervention and reducing non-urgent specialist referrals by utilizing AI-enabled technology in primary care settings, thereby enhancing community-level ophthalmic care.
More about DISA
DISA Limited is a company incorporated in Singapore, focusing on digital safety solutions through its subsidiary DiSa Digital Safety Pte. Ltd. The company is involved in providing innovative products that address safety and health needs.
Current Market Cap: S$10.51M
For a thorough assessment of 532 stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- 3 Penny Stocks to Watch Now, 1/9/25
- M&A News: Arm Holdings Explores Possible Takeover of Ampere Computing
- M&A News: Constellation Energy’s $30B Calpine Takeover Takes Shape
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
